Eli Lilly, Novartis Venture Fund and AbbVie Ventures are among the contributors to a series A round disclosed as the neurodegenerative disorder drug developer emerged from stealth.

Innovative region: Texas

The Sberbank-backed online lender has announced the appointment of a new chief executive alongside its latest round.

Shares in the antibody discovery platform developer, advancing UBC research, opened at more than three times their IPO price to net it a valuation topping $15bn.

Stanford University has scored an exit after photosensitive polymer-based 3D printing business Origin agreed to a $100m acquisition.

The Eli Lilly-backed antibody discovery platform developer's shares opened at more than three times their IPO price to net it a valuation topping $15bn.

TDK Ventures has scored an exit after 3D printing technology developer Origin after Stratasys agreed to buy it in a deal that could reach $100m.

Snowflake, Hewlett Packard Enterprise and Salesforce Ventures helped the enterprise AI platform developer hit a $2.8bn valuation.

The ride hailing service has sold its Uber Elevate subsidiary to urban aircraft developer and portfolio company Joby alongside a new $75m investment.

This latest funding round for the CAA-backed meditation app developer doubled its valuation to $2bn and brought its total funding to $217m.